Street dealers across the U.S. are adding potent synthetic opioids to drug supplies in what federal officials say could be ...
Q4 2024 Earnings Call Transcript March 6, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0 ...
Over the years many celebrities have divulged their deepest and darkest secrets through the release of shocking tell-all ...
Experts say that a summer holiday is just the tonic to improve our health, from helping our hearts to extending lifespan. So how can you get the best out of your break?
NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain Treatment ...
Equities researchers at William Blair increased their Q1 2025 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a report released on Monday, March 3rd. William Blair analyst M.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results